← Back to Clinical Trials
Recruiting NCT06291766

NCT06291766 Gestational Diabetes After Gastric Bypass Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06291766
Status Recruiting
Phase
Sponsor Region Skane
Condition Diabetes, Gestational
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2024-01-01
Primary Completion 2028-12

Trial Parameters

Condition Diabetes, Gestational
Sponsor Region Skane
Study Type INTERVENTIONAL
Phase N/A
Enrollment 120
Sex FEMALE
Min Age 18 Years
Max Age 50 Years
Start Date 2024-01-01
Completion 2028-12
Interventions
FreeStyle Libre 2, continous glucose monitoring

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this trial is to compare different means of glucose monitoring in women with gestational diabetes and a history of gastric bypass surgery. The main question it aims to answer is: How does continous glucose monitoring impact the treatment and affect pregnancy outcome in these women. Participants will be randomized to either continous glucose monitoring or regular capillary glucose measurements during the last trimester of their pregnancy. Researchers will compare the glucose measurement outcomes, the glucose lowering treatment given and pregnancy outcomes between groups.

Eligibility Criteria

Inclusion Criteria: * Understands written and spoken Swedish * Previous Gastric Bypass surgery * Diagnosed with gestational diabetes according to our local criteria * Planned follow up at the Specialized Maternity Ward at Skane University Hospital * Understands the use of CGM and is willing to use the system * Have signed informed consent Exclusion Criteria: * Other kinds of bariatric surgery

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology